Posts tagged “Biotech & Life Science”

Updated 12:02 p.m. Thursday

Biotech, pharma services provider moving HQ to Durham

Alcami ​Alcami, a leading product development and manufacturing services provider for the pharmaceutical and biotechnology sectors, plans to finish relocating its international headquarters from Wilmington to Durham in 2018.

Updated 11:57 a.m. Thursday

Premium Lock Artificial heart through 3D printing could be major advance (+ video)

Engineers at ETH Zurich used 3D printing to make a soft, artificial heart made of the implantable material, according to research published last week in the journal Artificial Organs. Is a heart made of silicone within reach? Plus: Watch a video overview and read the full announcement.

6:36 a.m. Thursday

NCBiotech company directory is new - and free - again

The price is right - free -- and the content is rich. It's the newly published 2017-18 print edition of the NCBiotech Company Directory.

NC Biotech directory NC Biotech directory

Updated 11:01 a.m. Wednesday

Garner-based Growers Holdings harvests $1M

​A Garner-based company that helps farmers get more crops from their land has raised $1 million in a private equity offering, according to a filing Tuesday with the Securities and Exchange Commission.

Growers at work Growers at work

Updated 11:00 a.m. Wednesday

Time running out for startups to apply for SEBIO Forum

Privately owned life science companies looking for funding still have a few days to apply for a chance to pitch their stories to potential investors and partners at the 2017 SEBIO Investor and Partnering Forum in Pinehurst this fall.

SEBIO SEBIO

6:45 a.m. Monday

Bullish on ag tech, Alexandria creating R&D 'mega campus' in RTP

Already a major landlord in the Research Triangle Park, California-based Alexandria Real Estate Equities is developing a unique multi-tenant research and development campus in the Research Triangle Park to drive North Carolina's global leadership in agricultural biotechnology.

Pproposed entryway to Alexandria Center for AgTech Pproposed entryway to Alexandria Center for AgTech

6:00 a.m. Monday

Science Says: Not all cancers need treatment right away

Cancer research The biopsy shows cancer, so you have to act fast, right? Not necessarily, if it's a prostate tumor. Long-term results are in from one of the few studies comparing these options in men with tumors confined to the prostate. After 20 years, death rates were roughly similar for those who had immediate surgery and those initially assigned to monitoring, and surgery had more side effects.

5:35 a.m. Monday

Give us a shout: WTW wants to hear from you - send us news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

5:20 a.m. Monday

WTW's week in review: 57 headlines not to be missed, part three

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire over this past week, part three.

5:15 a.m. Monday

WTW's week in review: 57 headlines not to be missed, part two

Triangle headlines Here's a look back at technology, life science and other related news as reported in WRAL TechWire for this past week, part two.

5:00 a.m. Monday

WTW's week in review: 57 headlines not to be missed, part one

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire for this past week, part one.

July 14

Raleigh-based biotech seeks orphan drug status for ulcerative colitis therapy

Innovate Biopharmaceuticals, a clinical-stage biotechnology company based in Raleigh, has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation for an oral therapy to treat pediatric ulcerative colitis.

Innovate Biopharmaceuticals Innovate Biopharmaceuticals

July 14

Durham biotech's valley fever therapy is on FDA fast track

Durham-based Viamet Pharmaceuticals has received Fast Track designation from the U.S. Food and Drug Administration for its anti-fungal agent VT-1598, a novel oral therapy for the treatment of valley fever.

Viamet's pipeline Viamet's pipeline

July 14

Eshelman-led pharma startup raises $6M (+ video)

Investor and veteran life science executive Fred Eshelman's latest startup has raised $6 million but wants another $7 million. Plus: A video overview of the company.

July 13

Premium Lock Novel leukemia treatment could be 1st US gene therapy + Alliance praises decision

Genetic research  A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. And the Alliance for Regenerative Medicine praises the decision.

July 13

Premium Lock Why is China buying the world's seeds? Food security

Chinese firms have spent $91 billion over the past decade purchasing nearly 300 foreign companies involved in agriculture, chemicals and food, according to Dealogic. Why the massive spending spree? Plus: Could China firm's acquisition of Syngenta boost N.C.?

Syngenta's new lab in RTP Syngenta's new lab in RTP

July 13

G1 Therapeutics names former GSK top exec Andrew Witty to board

Andrew Witty, formerly CEO of drug giant GlaxoSmithKline, is now a member of the board of directors at RTP-based G1 Therapeutics.

Andrew Witty         Andrew Witty

Techwire Inside Partners
The Skinny: A Blog by Rick Smith